LEADER 01447oam  2200421   450 
001 9910715195403321
005 20210407133648.0
035   $a(CKB)5470000002508056
035   $a(OCoLC)1225927088$z(OCoLC)1230502516$z(OCoLC)1231541361
035   $a(EXLCZ)995470000002508056
100   $a20201207g20209999  ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEasy Medication Access and Treatment for Opioid Addiction Act $ereport (to accompany H.R. 2281)
210  1$a[Washington, D.C.] :$c[U.S. Government Publishing Office],$d[2020]-
215   $a1 online resource (volumes)
225 1 $aRept. / 116th Congress, 2d session, House of Representatives ;$v116-587
300   $a"November 16, 2020"--Part 1.
320   $aIncludes bibliographical references.
517   $aEasy Medication Access and Treatment for Opioid Addiction Act 
606   $aDrug accessibility$zUnited States
606   $aOpioid abuse$xTreatment$zUnited States
608   $aLegislative materials.$2lcgft
615  0$aDrug accessibility
615  0$aOpioid abuse$xTreatment
801  0$bGPO
801  1$bGPO
801  2$bOCLCO
801  2$bOCLCF
801  2$bDWP
801  2$bGPO
906   $aBOOK
912   $a9910715195403321
996   $aEasy Medication Access and Treatment for Opioid Addiction Act$93522065
997   $aUNINA